Carmat (PAR: ALCAR)

Last close As at 07/11/2026

—

— 0.00 (0.00%)

Market capitalisation

—

Carmat is developing a biocompatible, artificial heart to satisfy the lack of donor hearts available for terminal heart failure patients. The development process combines the expertise of a wide range of technical and medical experts.

Latest Insights

View More

Healthcare | edison tv

Carmat: Edison Open House Healthcare 2022

Healthcare | Update

Carmat — Implantation momentum

Healthcare | edison tv

Carmat – Edison Open House interview

Healthcare | edison tv

Carmat – executive interview with Stéphane Piat

Market Data

Share Price —
Market Cap —
52-Week High —
52-Week Low —
% Change 1M
% Change 6M —
% Change 12M
Ave. Daily Volume 1yr —

Sector

Healthcare

Update

Healthcare

Carmat — Update 15 July 2016

Update

Healthcare

Carmat — Update 5 May 2016